In this episode of Skincare Confidential, Dr. Ted Lain interviews Carl D'Ruiz, a key figure in the skincare industry, about the introduction of a new sunscreen filter, Bemotrizinol (Parsol® Shield), to the U.S. market. They discuss the long-standing regulatory challenges that have hindered the approval of new UV filters, the implications for public health, and the role of DSM in innovating skincare solutions. The conversation highlights the importance of transparency in ingredient safety and the need for updated regulations to keep pace with global standards. Carl shares insights into DSM's commitment to public health and the future of sunscreen filters in the U.S. Be sure to check out our YouTube page to see all of these conversations: https://www.youtube.com/@skincareconfidentialpodcastTakeawaysA new UV filter has not been introduced in the U.S. for 26 years. The FDA's regulations for sunscreen are complex and outdated. Public health is at risk due to limited sunscreen options. DSM is leading the way in bringing new filters to market. Bemotrizinol (Parsol® Shield)has a long history of safe use in Europe. Consumer preferences impact sunscreen usage and public health. Transparency in ingredient safety is crucial for consumer trust. New regulations are being implemented to improve safety standards. The skincare industry is evolving with innovative ingredients. Collaboration between companies and regulators is essential for progress. DISCLAIMER: This podcast is not intended to provide diagnosis, treatment, or medical advice. Content provided in this podcast is for educational purposes only. Please consult with a physician regarding any health-related diagnosis or treatment.See omnystudio.com/listener for privacy information.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related